Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis

Lina Orikabe1, Hidenori Yamasue, Hideyuki Inoue

  • 1Department of Neuropsychiatry, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Insights

Methamphetamine psychosis is linked to significant gray matter volume reductions in the amygdala and hippocampus. These medial temporal lobe changes, particularly in the amygdala, may distinguish methamphetamine psychosis from other psychotic disorders.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Radiology

Background:

  • Methamphetamine psychosis shares symptoms with schizophrenia, but its neurobiological underpinnings, specifically medial temporal lobe structure, are not well understood.
  • Previous research indicates gray matter reductions in schizophrenia patients, but similar data for methamphetamine psychosis is lacking.
  • Methamphetamine-induced psychosis is considered a model for exogenous psychosis, making its structural brain changes a key research area.

Purpose of the Study:

  • To investigate and compare gray matter volumes in the amygdala and hippocampus between patients with methamphetamine psychosis and healthy controls.
  • To determine if methamphetamine psychosis is associated with structural reductions in medial temporal lobe regions.
  • To explore potential differences in the degree of volume reduction between the amygdala and hippocampus in methamphetamine psychosis.

Main Methods:

  • Acquisition of magnetic resonance images (MRI) from 20 patients with methamphetamine psychosis and 20 matched healthy controls.
  • Utilizing a manual tracing methodology to accurately measure gray matter volume of the amygdala and hippocampus.
  • Statistical analysis to compare regional brain volumes between the patient group and the control group, controlling for global brain volumes.

Main Results:

  • Significant bilateral gray matter volume reductions in both the amygdala and hippocampus were observed in patients with methamphetamine psychosis compared to controls.
  • The reduction in amygdala volume was significantly more pronounced than the reduction in hippocampus volume.
  • These regional gray matter reductions remained significant even after accounting for differences in total brain volumes.

Conclusions:

  • Methamphetamine psychosis is associated with significant gray matter volume reductions in the amygdala and hippocampus.
  • The greater degree of volume reduction in the amygdala compared to the hippocampus may be a specific characteristic of methamphetamine psychosis.
  • These findings contribute to understanding the neurobiological differences between methamphetamine psychosis and other psychotic disorders like schizophrenia.